Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.
about
Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsAdvances in the Molecular Analysis of Soft Tissue Tumors and Clinical ImplicationsNext generation sequencing of acute myeloid leukemia: influencing prognosis.Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches.Comparison of somatic mutation calling methods in amplicon and whole exome sequence data.Targeted next-generation sequencing at copy-number breakpoints for personalized analysis of rearranged ends in solid tumors.Detection of gene rearrangements in targeted clinical next-generation sequencing.Clinical microbiology informatics.Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.Analyzing the most frequent disease loci in targeted patient categories optimizes disease gene identification and test accuracy worldwide.Performance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence dataClinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.Captured metagenomics: large-scale targeting of genes based on 'sequence capture' reveals functional diversity in soils.Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMutGene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing AnalysesAre results of targeted gene sequencing ready to be used for clinical decision making for patients with acute myelogenous leukemia?Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsGenomic tools in acute myeloid leukemia: From the bench to the bedsideNext-generation sequencing-based panel testing for myeloid neoplasms.The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.Overview of Target Enrichment Strategies.Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.Validation of a next-generation sequencing assay for clinical molecular oncology.Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis.EAGLE: Explicit Alternative Genome Likelihood Evaluator.Detecting Copy Number Variation via Next Generation Technology
P2860
Q26864332-F5C846CD-F790-4CD1-8707-1345970FA9F8Q27021848-408F9767-E879-4949-9468-D9FBD5E2C980Q27690776-AF3ED2E0-9296-496D-81FE-027DD6E57573Q30729747-DCAA0577-38D6-40EA-999E-EC8BFA618619Q30788162-A6B13674-0A6B-4793-B57D-F98EB7EB558FQ33769009-0A616350-5DC7-46A9-8D71-D1709EAD5E1FQ33833183-1C618E46-D491-4DE0-9E3F-BF36089CB364Q34297646-6D9C6A67-D622-4189-BEFC-31FC5F95ECDBQ34786722-65DF25DE-A461-4695-AE17-E3190406A39CQ35033414-31BCAB66-6E92-4A36-AB14-B68B05E05522Q35037810-F7107225-EBE7-4E10-8A66-96D8D9D7E105Q35095944-A2E09816-17EB-4B7A-97EF-6C91C9C70EC3Q35584856-2087B453-AFCE-4570-B02D-9A9CF4D3C4A4Q35816844-61E8D7EB-DE5F-4E74-B297-4EC5011BB215Q36265829-CEA7F020-9A46-4FF2-A22F-F69EE39F7537Q36939219-AAC3F362-6E58-4A0E-A2F8-E6275EC46708Q36949511-E090DBCC-3651-439A-A919-3B0EC80102D0Q37193365-B853FDFB-3A69-4FE1-A10B-333083E9499BQ37688148-11E58A34-B3F7-4563-B910-746F13C0240DQ38182932-416D0B25-7F08-4EF5-91C0-B69F6B0BC8A9Q38453790-A2B1F87E-71AF-4FCD-9200-5BCB0BE7435AQ38481997-2C68C4A1-5572-44DE-BE84-9EE87345A497Q38596044-1B3F64A7-5E96-49BC-8DF4-F27EAF524F63Q43561078-A1082AE6-EC0C-45F5-A028-B3E026C3F398Q45823548-897DF01B-58A1-4A34-86CF-B95B17176772Q47135060-DB72AA51-D63C-424F-B0C7-BA43B94B9367Q53459692-3BE02C9C-2C5F-4A11-8FC2-97CBF8696AA7Q55395587-B49739B7-2F11-4E41-A6D6-D775B18C830BQ57783644-ED9CBAC8-D822-490B-826F-DD46B9A7395F
P2860
Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeted next generation seque ...... nd translocations in leukemia.
@en
Targeted next generation seque ...... nd translocations in leukemia.
@nl
type
label
Targeted next generation seque ...... nd translocations in leukemia.
@en
Targeted next generation seque ...... nd translocations in leukemia.
@nl
prefLabel
Targeted next generation seque ...... nd translocations in leukemia.
@en
Targeted next generation seque ...... nd translocations in leukemia.
@nl
P2093
P2860
P1433
P1476
Targeted next generation seque ...... nd translocations in leukemia.
@en
P2093
Eric J Duncavage
Haley J Abel
John D Pfeifer
Philippe Szankasi
Todd W Kelley
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.29
P577
2012-03-16T00:00:00Z